ClearOne Announces the Addition of a 4-Channel Access Point and a 4-Bay Dock for its Award-Winning DIALOG® UVHF Wireless Microphone System
ClearOne, a global leader in conferencing, collaboration, and network streaming solutions, has announced the addition of a 4-channel Access Point and a 4-bay Dock to its award-winning DIALOG® UVHF Wireless Microphone System.
This press release features multimedia. View the full release here:
DIALOG® UVHF Wireless Microphone (Photo: Business Wire)
'We are excited to introduce these new additions to our DIALOG UVHF Wireless Microphone System,' said Derek Graham, CEO of ClearOne. 'The 4-channel Access Point and 4-bay Dock offer significant benefits like lower cost, system flexibility and a smaller form factor for the dock. This translates to increased value for our customers, making our high-quality wireless audio solutions more accessible and a better fit for applications that require fewer microphones.'
With these new additions, the Dialog UVHF Wireless Microphone System now offers the flexibility to choose between an Access Point with 8 or 4 Dante channels and a Charger Dock capable of charging 8 or 4 microphones.
The lightweight plenum-rated access point provides versatile mounting options for wall, ceiling, tabletop, or pole mounting, including VESA mount holes. The Dante-powered system utilizes the Dante Access Point for optimal signal transmission and system flexibility. The DIALOG UVHF is the only system with a wireless access point delivering antenna redundancy and diversity, maintaining audio quality in harsh environments. A wired Ethernet connection enables connection with management software via web browsers.
The DIALOG® UVHF Wireless Microphone System combines class-leading flexibility, Power over Ethernet (PoE) simplicity, and Dante technology, offering up to 350 usable frequencies. An optional DIALOG UVHF Dante interface offers eight Euroblock balanced analog outputs, including mixed output, USB audio output, and eight GPIOs. This system provides professional-quality audio conferencing, video collaboration, and sound reinforcement for various applications and room types. Businesses and institutions benefit from a flexible wireless microphone system that addresses audio pickup needs for a wide variety of applications and rooms. With various microphone types available, including lavalier, lanyard, and headset-type bodypack microphones, the DIALOG UVHF provides unmatched flexibility for integrators, room designers, and meeting hosts. The DIALOG UVHF provides an ideal experience for hybrid and in-person conferencing, video collaboration, and voice lift in various settings.
Standard to ClearOne solutions, the DIALOG UVHF supports all leading collaboration platforms, including Microsoft Teams®, Google Meet®, Zoom®, and WebEx®, ensuring seamless connectivity for in-person and hybrid users regardless of their personal system, ensuring meeting equity.
The Dialog® UVHF Wireless Microphone System is backed by a three-year warranty.
For more information about the Dialog UVHF Microphone System, click here.
ClearOne will showcase its full range of solutions for modern hybrid work and learning environments at ISE 2025, Stand No. 2N220.
SOURCE: ClearOne, Inc.
Copyright Business Wire 2025.
PUB: 01/27/2025 09:10 AM/DISC: 01/27/2025 09:10 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a few seconds ago
- Business Wire
Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 fourth quarter and full year ended June 30, 2025. Fiscal-year 2025 fourth quarter total net revenue of $262.9 million decreased 12% from the prior-year period; however, increased 1% on a sequential basis from the fiscal-year 2025 third quarter. Net income from continuing operations of $18.0 million, or $0.22 per share, in the fiscal-year 2025 fourth quarter compared to $60.9 million, or $0.57 per share, in the prior-year period. Adjusted EBITDA* of $68.9 million in the fiscal-year 2025 fourth quarter decreased 34% from the prior-year period and decreased 4% on a sequential basis from the fiscal-year 2025 third quarter. Adjusted EPS* of $0.43 in the fiscal-year 2025 fourth quarter decreased 30% from the prior-year period and decreased 2% on a sequential basis from the fiscal-year 2025 third quarter. "I'm pleased to report that we had a strong finish to the year despite the contract renewal headwinds, which are now mostly behind us. Our overall revenue and profitability for the year exceeded our expectations largely due to better-than-anticipated results in our Supply Chain Services segment," said Michael J. Alkire, Premier's President and CEO. "In addition, we continued to return meaningful capital to stockholders through our quarterly cash dividend and the completion of a $200 million accelerated share repurchase program." On October 1, 2024, the company announced that it had divested the S2S Global direct sourcing business. As such, and unless stated otherwise, all results presented in the following release reflect those of continuing operations. In addition, as the company's efforts to transfer to partners or wind down certain components of the Contigo Health business remain ongoing, results presented in this release continue to include contributions from that business. However, because of the expected transition and/or wind-down, the company is providing certain financial measures that exclude contributions from this business, and tables are included at the end of this release that reconcile the impact of the Contigo Health business on certain financial measures in the periods presented. Consolidated Non-GAAP Financial Highlights of Continuing Operations* Three Months Ended June 30, Year Ended June 30, (in thousands, except per share data) 2025 2024 % Change 2025 2024 % Change Adjusted EBITDA: Supply Chain Services $ 89,986 $ 109,617 (18 %) $ 326,902 $ 409,669 (20 %) Performance Services 17,170 32,820 (48 %) 60,692 113,845 (47 %) Total segment adjusted EBITDA 107,156 142,437 (25 %) 387,594 523,514 (26 %) Corporate (38,300 ) (38,424 ) — % (134,474 ) (134,529 ) — % Adjusted EBITDA $ 68,856 $ 104,013 (34 %) $ 253,120 $ 388,985 (35 %) Adjusted EBITDA excluding Contigo Health $ 71,108 $ 106,045 (33 %) $ 260,435 $ 396,191 (34 %) Adjusted net income $ 35,743 $ 64,482 (45 %) $ 133,752 $ 237,846 (44 %) Adjusted EPS $ 0.43 $ 0.61 (30 %) $ 1.46 $ 2.08 (30 %) Adjusted EPS excluding Contigo Health $ 0.46 $ 0.64 (28 %) $ 1.54 $ 2.17 (29 %) Expand * These are non-GAAP financial measures. Refer to "Premier's Use and Definitions of Non-GAAP Measures" below and the supplemental financial information at the end of this release for information on the company's use of non-GAAP measures and a reconciliation of reported GAAP results to non-GAAP results. Expand Fiscal-Year 2026 Guidance Certain statements in this release, including without limitation, those in this section, are forward-looking statements. For additional information regarding the use and limitations of such statements, refer to "Cautionary Note Regarding Forward-Looking Statements" below. Based on its current outlook and the realization of the assumptions outlined below, the company expects the following: [1] Adjusted EBITDA, adjusted net income, adjusted EPS and free cash flow presented in this financial guidance are forward-looking non-GAAP measures. Refer to "Premier's Use and Definitions of Non-GAAP Measures" below for information on the company's use of non-GAAP measures. The company does not provide forward-looking guidance on a GAAP basis as certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. Total Net Revenue Excluding Contigo Health is also a forward-looking non-GAAP measure. Refer to "Premier's Use of Forward-Looking Non-GAAP Measures" below for additional explanation. [2] As a result of the company's expectation that the remaining operations of Contigo Health will be substantially, if not entirely, transitioned to partners or wound down by December 31, 2025, guidance is being presented excluding financial contributions from this business. Expand Results of Operations for the Three Months Ended June 30, 2025 (As compared with the three months ended June 30, 2024) GAAP net revenue of $262.9 million decreased 12% from $300.2 million in the prior-year period. Refer to the "Supply Chain Services" and "Performance Services" sections below for discussion on the factors that impacted net revenue during the quarter. GAAP net income from continuing operations of $18.0 million decreased by $42.8 million from $60.9 million in the prior-year period primarily due to lower net revenue and an increase in operating expenses related to stock-based compensation expense and current period asset impairments. GAAP diluted EPS from continuing operations of $0.22 decreased by $0.35 from $0.57 in the prior-year period due to the aforementioned drivers affecting GAAP net income from continuing operations, partially offset by a decrease in the diluted weighted average shares outstanding as a result of share repurchases under the company's $1 billion share repurchase authorization announced in February 2024 ("Share Repurchase Authorization"), further discussed below under "Return of Capital to Stockholders". Adjusted EBITDA of $68.9 million decreased 34% from $104.0 million in the prior-year period. Refer to the "Supply Chain Services" and "Performance Services" sections below for discussion on the factors that impacted the Adjusted EBITDA during the quarter. Adjusted net income of $35.7 million decreased 45% from $64.5 million in the prior-year period primarily as a result of the same factors that impacted adjusted EBITDA and an increase in interest expense due to higher borrowings on the company's revolving credit facility, partially offset by a decrease in the effective income tax rate in the current-year period. Adjusted EPS of $0.43 decreased 30% from $0.61 in the prior-year period. Segment Results (For the fiscal fourth quarter of 2025 as compared with the fiscal fourth quarter of 2024) Supply Chain Services Supply Chain Services segment net revenue of $170.0 million decreased 8% from $184.4 million in the prior-year period largely due to lower net administrative fees revenue. Net administrative fees revenue of $150.1 million decreased 10% from $166.1 million in the prior-year period, primarily driven by the expected increase in the aggregate blended member fee share, partially offset by continued growth in member purchasing as a result of increased utilization of contracts with existing members and from the recruitment and onboarding of new members. Software licenses, other services and support revenue of $19.9 million increased 9% from $18.3 million in the prior-year period mainly driven by continued growth from new engagements in the supply chain co-management business and further expansion of the company's digital supply chain solutions to providers and suppliers. Segment adjusted EBITDA of $90.0 million decreased 18% from $109.6 million in the prior-year period largely due to the decrease in net administrative fees revenue and additional investments in the supply chain co-management business to support ongoing growth. Performance Services Performance Services segment net revenue of $92.9 million decreased 20% from $115.8 million in the prior-year period primarily due to lower revenue in the consulting business as well as the timing of license revenue. Segment adjusted EBITDA of $17.2 million decreased 48% from $32.8 million in the prior-year period mainly due to the decrease in revenue partially offset by a decrease in employee-related costs. Liquidity and Cash Flows As of June 30, 2025, cash and cash equivalents were $83.7 million compared with $125.1 million as of June 30, 2024, and the company's five-year, $1.0 billion revolving credit facility ("Credit Facility") had an outstanding balance of $280.0 million. Net cash provided by operating activities from continuing operations ("operating cash flow") for the year ended June 30, 2025 of $417.8 million increased from $278.1 million in the prior year mainly due to cash taxes paid in the prior year on proceeds received from the sale the company's non-healthcare GPO operations, cash received in the current year from a derivative lawsuit settlement of $57.0 million and a $17.6 million cash distribution received in the current year from a minority investment. Net cash used in investing activities for the year ended June 30, 2025 of $102.1 million increased from $68.5 million in the prior year due to the business acquisition of IllumiCare, Inc. partially offset by net cash received from the sale of certain assets and liabilities including Contigo Health's wrap network. Net cash used in financing activities for the year ended June 30, 2025 of $340.7 million increased from $192.7 million in the prior year due to the timing of net cash proceeds received from the sale of the company's non-healthcare GPO operations largely received in the prior year. The change was offset by the current-year net borrowings and the prior-year repayment under the company's Credit Facility, as well as a decrease in cash dividends paid in the current year as a result of share repurchases. Non-GAAP free cash flow for the year ended June 30, 2025 was $180.5 million compared with $228.0 million in the prior year. In addition to some of the factors that affected operating cash flow, the decrease was primarily due to the timing of cash payments to OMNIA related to our non-healthcare channel partnership agreement. Refer to "Premier's Use and Definitions of Non-GAAP Measures" below and the supplemental financial information at the end of this release for information on the company's use of this and other non-GAAP financial measures and a reconciliation of reported GAAP results to non-GAAP results. Return of Capital to Stockholders In February 2024, the company announced that its Board of Directors ("Board") approved the Share Repurchase Authorization. Pursuant to the Share Repurchase Authorization, which expired on June 30, 2025, the company has repurchased an aggregate of $800.0 million of its Common Stock, which includes the August 2025 completion of the $200.0 million accelerated share repurchase program announced in February 2025 (the "2025 ASR"). Additional details will be provided in Premier's Form 10-K for the year ended June 30, 2025, expected to be filed with the SEC shortly after the issuance of this release. During fiscal-year 2025, the company paid aggregate dividends of $77.4 million to holders of its Common Stock. On August 17, 2025, the Board declared a quarterly cash dividend of $0.21 per share, payable on September 15, 2025 to stockholders of record on September 1, 2025. Conference Call and Webcast Premier will host a conference call to provide additional detail around the company's performance and outlook today at 8:00 a.m. ET. The call will be webcast live from the company's website and, along with the accompanying presentation, will be available at the following link to the company's Events and Presentations page at Premier Events. The webcast should be accessed 10 minutes prior to the conference call start time. A replay of the webcast will be available for one year following the conclusion of the live broadcast and will be accessible on the company's website under Events and Presentations at For those parties who do not have internet access, the conference call may be accessed by calling one of the below telephone numbers and asking to join the Premier, Inc. call: About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. Please visit Premier's news and investor sites on as well as X, Facebook, LinkedIn, YouTube, Instagram and Premier's blog for more information about the company. Premier's Use and Definitions of Non-GAAP Measures Premier uses EBITDA, adjusted EBITDA, segment adjusted EBITDA, adjusted net income, adjusted earnings per share, and free cash flow. These are non-GAAP financial measures that are not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP financial measures used by other companies. We include these non-GAAP financial measures to facilitate a comparison of the company's operating performance on a consistent basis from period to period and to provide measures that, when viewed in combination with its results prepared in accordance with GAAP, we believe allow for a more complete understanding of factors and trends affecting the company's business than GAAP measures alone. Management believes EBITDA, adjusted EBITDA and segment adjusted EBITDA assist the company's board of directors, management and investors in comparing the company's operating performance on a consistent basis from period to period by removing the impact of the company's earnings elements attributable to the company's asset base (primarily depreciation and amortization), certain items outside the control of management, e.g., taxes, other non-cash items (such as impairment of intangible assets, purchase accounting adjustments and stock-based compensation), non-recurring items (such as strategic initiative and restructuring-related expenses) and income and expense that have been classified as discontinued operations from operating results. Management believes adjusted net income and adjusted earnings per share assist the company's board of directors, management and investors in comparing our net income and earnings per share on a consistent basis from period to period because these measures remove non-cash items (such as impairment of intangible assets, purchase accounting adjustments and stock-based compensation) and non-recurring items (such as strategic initiative and restructuring-related expenses) and eliminate the variability of non-controlling interest and equity in net income of unconsolidated affiliates. Management believes free cash flow is an important measure because it represents the cash that the company generates after payments to certain former limited partners that elected to execute a Unit Exchange and Tax Receivable Agreement ('Unit Exchange Agreement") in connection with our August 2020 restructuring, capital investment to maintain existing products and services and ongoing business operations, as well as development of new and upgraded products and services to support future growth and cash payments to OMNIA for the sale of future revenues and tax payments on proceeds received from the sale of future revenues. Free cash flow is important because it enables the company to seek enhancement of stockholder value through acquisitions, partnerships, joint ventures, investments in related or complementary businesses and/or debt reduction. Also, adjusted EBITDA and free cash flow are supplemental financial measures used by the company and by external users of our financial statements and are considered to be indicators of the operational strength and performance of our business. Adjusted EBITDA and free cash flow measures allow us to assess our performance without regard to financing methods and capital structure and without the impact of other matters that we do not consider indicative of the operating performance of our business. More specifically, segment adjusted EBITDA is the primary earnings measure we use to evaluate the performance of our business segments. Non-recurring items are income or expenses and other items that have not been earned or incurred within the prior two years and are not expected to recur within the next two years. Such items include acquisition- and disposition-related expenses, strategic initiative- and restructuring-related expenses, loss on disposal of long-lived assets, income and expense that has been classified as discontinued operations and other reconciling items. Non-cash items include stock-based compensation expense and asset impairments. Non-operating items include gains or losses on the disposal of assets, interest and investment income or expense, equity in net income of unconsolidated affiliates and operating income from revenues sold to OMNIA in connection with the sale of non-healthcare GPO member contracts, less royalty payments retained. EBITDA is defined as net income before income or loss from discontinued operations, net of tax, interest and investment income or expense, net, income tax expense, depreciation and amortization and amortization of purchased intangible assets. Adjusted EBITDA is defined as EBITDA before merger and acquisition-related expenses and non-recurring, non-cash or non-operating items. Segment adjusted EBITDA is defined as the segment's net revenue less cost of revenue and operating expenses directly attributable to the segment excluding depreciation and amortization, amortization of purchased intangible assets, merger and acquisition-related expenses and non-recurring or non-cash items. Operating expenses directly attributable to the segment include expenses associated with sales and marketing, general and administrative, and product development activities specific to the operation of each segment. General and administrative corporate expenses that are not specific to a particular segment are not included in the calculation of segment adjusted EBITDA. Segment adjusted EBITDA also excludes any income and expense that has been classified as discontinued operations and operating income from revenues sold to OMNIA in connection with the sale of non-healthcare GPO member contracts, less royalty payments retained. Adjusted net income is defined as net income attributable to Premier (i) excluding income or loss from discontinued operations, net, (ii) excluding income tax expense, (iii) excluding the effect of non-recurring or non-cash items, including certain strategic initiative- and restructuring-related expenses, (iv) reflecting an adjustment for income tax expense on Non-GAAP net income before income taxes at our estimated annual effective income tax rate, adjusted for unusual or infrequent items, (v) excluding the equity in net income of unconsolidated affiliates and (vi) excluding operating income from revenues sold to OMNIA in connection with the sale of non-healthcare GPO member contracts, less royalty fees retained, imputed interest expense and associated income tax expense. Adjusted earnings per share is adjusted net income divided by diluted weighted average shares. Free cash flow is defined as net cash provided by operating activities from continuing operations less (i) early termination payments to certain former limited partners that elected to execute a Unit Exchange Agreement in connection with our August 2020 restructuring, (ii) purchases of property and equipment and (iii) cash payments to OMNIA for the sale of future revenues and tax payments on proceeds received from the sale of future revenues. Free cash flow does not represent discretionary cash available for spending as it excludes certain contractual obligations such as debt repayments. To properly and prudently evaluate our business, readers are urged to review the reconciliation of these non-GAAP financial measures, as well as the other financial tables, included at the end of this release. Readers should not rely on any single financial measure to evaluate the company's business. In addition, the non-GAAP financial measures used in this release are susceptible to varying calculations and may differ from, and may therefore not be comparable to, similarly titled measures used by other companies. The Company has revised the definitions for adjusted EBITDA, segment adjusted EBITDA, adjusted net income and free cash flow from the definitions reported in the 2024 Annual Report. Adjusted EBITDA and segment adjusted EBITDA definitions were revised to exclude operating income from revenues sold to OMNIA in connection with the sale of non-healthcare GPO member contracts, less royalty fees retained. The adjusted net income definition was revised to exclude operating income from revenues sold to OMNIA in connection with the sale of non-healthcare GPO member contracts, less royalty fees retained, imputed interest expense and associated income tax expense. Free cash flow was revised to exclude the cash payments to OMNIA for the sale of future revenues and tax payments on proceeds received from the sale of future revenues. For comparability purposes, prior year non-GAAP financial measures are presented based on the current definitions in the above section. In addition to the foregoing, this release and the reconciliations of our non-GAAP financial measures included at the end of this release include the presentation of additional fiscal-year 2025 non-GAAP financial measures including net revenue excluding Contigo Health, adjusted EBITDA excluding Contigo Health and adjusted earnings per share excluding Contigo Health. As the company continues to own and operate Contigo Health's remaining businesses, GAAP financial results presented in this release include contributions from these remaining businesses. The company expects that these remaining businesses will be substantially, if not entirely, transitioned to partners or wound down by December 31, 2025. Given the time span that has been required to effectuate the disposition and wind-down of Contigo Health, the company currently does not expect that it will qualify to treat this business as a discontinued operation in fiscal-year 2025. However, because of the expected transition and/or wind-down, guidance presented in this release excludes financial contributions from these remaining businesses. Accordingly, we believe that providing supplemental non-GAAP financial measures that align with our fiscal-year 2025 guidance allow for a better understanding of that guidance. Further information on Premier's use of non-GAAP financial measures is available in the 'Our Use of Non-GAAP Financial Measures' section of Premier's Form 10-K for the year ended June 30, 2025, expected to be filed with the SEC shortly after this release, and which will also be made available on Premier's website at Premier's Use of Forward-Looking Non-GAAP Measures The company does not meaningfully reconcile guidance for non-GAAP adjusted EBITDA, non-GAAP adjusted net income and non-GAAP adjusted earnings per share to net income attributable to stockholders or earnings per share attributable to stockholders (and accordingly does not meaningfully reconcile free cash flow guidance, which is based on adjusted EBITDA) because the company cannot provide guidance for the more significant reconciling items between net income attributable to stockholders and each of these metrics without unreasonable effort. This is due to the fact that future period non-GAAP guidance includes adjustments for items not indicative of our core operations, which may include, without limitation, items included in the supplemental financial information for reconciliation of reported GAAP results to non-GAAP results. Such items include, but are not limited to, strategic and acquisition related expenses for professional fees; mark to market adjustments for put options and contingent liabilities; gains and losses on stock-based performance shares; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the company believes to be non-indicative of its ongoing operations. Such adjustments may be affected by changes in ongoing assumptions, judgements, as well as non-recurring, unusual or unanticipated charges, expenses or gains/losses or other items that may not directly correlate to the underlying performance of our business operations. The exact amount of these adjustments is not currently determinable but may be significant. As noted above, as a result of the company's expectation that the remaining businesses of Contigo Health will be substantially, if not entirely, transitioned to partners or wound down by December 31, 2025, the forward-looking guidance presented in this release (including Total Net Revenue Excluding Contigo Health, adjusted EBITDA, adjusted net income, adjusted EPS and free cash flow), excludes the financial contributions from these remaining businesses, in addition to any applicable adjustments for non-GAAP financial measures described above under "Premier's Use and Definitions of Non-GAAP Measures." With respect to these adjustments for Contigo Health, the company does not meaningfully reconcile guidance to GAAP measures because Contigo Health is expected to be transitioned to partners or wound down. Cautionary Note Regarding Forward-Looking Statements Statements made in this release that are not statements of historical or current facts, including, but not limited to, those related to our ability to advance our business strategies and improve healthcare, our ability to transition to partners or wind down the remaining operations of Contigo Health and the potential costs and expenses associated therewith, the potential benefits of share repurchases made pursuant to the share repurchase authorization approved by our Board in 2024 (including the recently completed 2025 ASR), the payment of dividends at current levels or at all, guidance on expected future financial performance and assumptions underlying that guidance, and our expected effective income tax rate, are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements, the achievement of which cannot be guaranteed. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as 'believes,' 'belief,' 'expects,' 'estimates,' 'intends,' 'anticipates' or 'plans' to be uncertain and forward-looking. Forward-looking statements may include comments as to Premier's beliefs and expectations regarding future events and trends affecting its business and are necessarily subject to risks and uncertainties, many of which are outside Premier's control. More information on risks and uncertainties that could affect Premier's business, achievements, performance, financial condition and financial results is included from time to time in the 'Cautionary Note Regarding Forward-Looking Statements,' 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of Premier's periodic and current filings with the SEC, including the information in those sections of Premier's Form 10-K for the year ended June 30, 2025, expected to be filed with the SEC shortly after the date of this release. Premier's periodic and current filings with the SEC are made available on Premier's website at Forward-looking statements speak only as of the date they are made, and Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events that occur after that date, or otherwise. Consolidated Balance Sheets (In thousands, except share data) June 30, 2024 Assets Cash and cash equivalents $ 83,725 $ 125,146 Accounts receivable (net of $6,339 and $1,392 allowance for credit losses, respectively) 99,092 100,965 Contract assets (net of $1,207 and $1,248 allowance for credit losses, respectively) 318,337 335,831 Prepaid expenses and other current assets 84,649 73,653 Current assets of discontinued operations — 119,662 Total current assets 585,803 755,257 Property and equipment (net of $820,043 and $742,063 accumulated depreciation, respectively) 201,481 205,711 Intangible assets (net of $332,522 and $294,333 accumulated amortization, respectively) 250,770 269,259 Goodwill 897,894 995,852 Deferred income tax assets 762,859 773,002 Deferred compensation plan assets 35,069 54,422 Investments in unconsolidated affiliates 262,621 228,562 Operating lease right-of-use assets 5,072 20,635 Other assets 95,505 98,749 Total assets $ 3,097,074 $ 3,401,449 Liabilities and stockholders' equity Accounts payable $ 19,619 $ 22,610 Accrued expenses 59,151 58,482 Revenue share obligations 347,306 292,792 Accrued compensation and benefits 99,019 100,395 Deferred revenue 22,548 19,642 Line of credit and current portion of long-term debt 280,000 1,008 Current portion of notes payable to former limited partners — 101,523 Current portion of liability related to the sale of future revenues 49,712 51,798 Other current liabilities 33,182 52,589 Current liabilities of discontinued operations 96 45,724 Total current liabilities 910,633 746,563 Liability related to the sale of future revenues, less current portion 590,727 599,423 Deferred compensation plan obligations 35,069 54,422 Operating lease liabilities, less current portion 2,007 11,170 Other liabilities 28,061 27,640 Total liabilities 1,566,497 1,439,218 Commitments and contingencies Stockholders' equity: Class A common stock, $0.01 par value, 500,000,000 shares authorized; 91,548,325 shares issued and 82,544,385 shares outstanding at June 30, 2025 and 111,456,454 shares issued and 105,027,079 shares outstanding at June 30, 2024 916 1,115 Treasury stock, at cost; 9,003,940 and 6,429,375 shares at June 30, 2025 and June 30, 2024, respectively (161,561 ) (250,129 ) Additional paid-in capital 2,176,318 2,105,684 (Accumulated deficit) retained earnings (485,045 ) 105,590 Accumulated other comprehensive loss (51 ) (29 ) Total stockholders' equity 1,530,577 1,962,231 Total liabilities and stockholders' equity $ 3,097,074 $ 3,401,449 Expand Consolidated Statements of Cash Flows (In thousands) 2025 2024 Operating activities Net income $ 30,833 $ 106,719 Adjustments to reconcile net income to net cash provided by operating activities: Net loss (income) from discontinued operations, net of tax 41,901 (2,500 ) Depreciation and amortization 117,631 128,754 Equity in net (income) loss of unconsolidated affiliates (11,972 ) 295 Deferred income taxes 27,076 (123,276 ) Stock-based compensation 23,154 23,290 Impairment of assets 144,481 140,053 Other, net (23,036 ) (4,518 ) Changes in operating assets and liabilities, net of the effects of acquisitions: Accounts receivable 3,006 (15,622 ) Contract assets 17,557 (39,265 ) Prepaid expenses and other assets 17,481 237 Accounts payable (3,108 ) (10,661 ) Revenue share obligations 54,514 30,504 Accrued expenses, deferred revenue, and other liabilities (21,709 ) 44,133 Net cash provided by operating activities from continuing operations 417,809 278,143 Net cash (used in) provided by operating activities from discontinued operations (16,380 ) 18,417 Net cash provided by operating activities $ 401,429 $ 296,560 Investing activities Purchases of property and equipment $ (82,649 ) $ (81,189 ) Proceeds from sale of assets 20,402 — Acquisition of businesses, net of cash acquired (39,848 ) — Sale of investment in unconsolidated affiliates — 12,753 Other — (30 ) Net cash used in investing activities $ (102,095 ) $ (68,466 ) Financing activities Payments on notes payable $ (102,531 ) $ (100,937 ) Proceeds from credit facility 435,000 — Payments on credit facility (155,000 ) (215,000 ) Proceeds from sale of future revenues 42,325 681,427 Payments on liability related to the sale of future revenues (53,107 ) (31,535 ) Cash dividends paid (77,445 ) (95,207 ) Repurchase of Class A common stock (400,191 ) (400,000 ) Payments on deferred consideration related to acquisition of business — (27,187 ) Payments on earn-out liabilities (22,700 ) (1,375 ) Other, net (7,084 ) (2,906 ) Net cash used in financing activities $ (340,733 ) $ (192,720 ) Effect of exchange rate changes on cash flows (22 ) (21 ) Net (decrease) increase in cash and cash equivalents (41,421 ) 35,353 Cash and cash equivalents at beginning of period 125,146 89,793 Cash and cash equivalents at end of period $ 83,725 $ 125,146 Expand _________________________________ (a) Early termination payments to certain former limited partners that elected to execute a Unit Exchange Agreement in connection with Premier's August 2020 restructuring are presented in the Consolidated Statements of Cash Flows under 'Payments made on notes payable." During the year ended June 30, 2025, the company paid $102.7 million to members, including imputed interest of $1.2 million which is included in net cash provided by operating activities from continuing operations. During the year ended June 30, 2024, the company paid $102.7 million to members, including imputed interest of $3.0 million which is included in net cash provided by operating activities from continuing operations. At June 30, 2025, the early termination payments were paid in full. (b) Cash payments to OMNIA for the sale of future revenues in connection with our sale of non-healthcare contracts to OMNIA are presented in the Consolidated Statements of Cash Flows under "Payments on liability related to the sale of future revenues." During the year ended June 30, 2025, the company paid $70.1 million to OMNIA, including imputed interest of $17.0 million which is included in net cash provided by operating activities from continuing operations. During the year ended June 30, 2024, the company paid $44.4 million to OMNIA, including imputed interest of $14.2 million which is included in net cash provided by operating activities from continuing operations. Expand Supplemental Financial Information (Unaudited) (In thousands) Three Months Ended Year Ended June 30, June 30, 2025 2024 2025 2024 Net income from continuing operations $ 18,018 $ 60,861 $ 72,734 $ 104,219 Interest expense, net 6,305 73 17,223 662 Income tax expense 7,083 25,723 25,315 42,302 Depreciation and amortization 20,052 20,636 79,442 81,728 Amortization of purchased intangible assets 9,499 9,794 38,189 47,026 EBITDA 60,957 117,087 232,903 275,937 Stock-based compensation 7,669 205 23,700 23,876 Acquisition- and disposition-related expenses 2,520 4,117 6,943 12,612 Strategic initiative and restructuring-related expenses 6,914 (119 ) 13,007 2,850 Operating income from revenues sold to OMNIA (16,840 ) (15,624 ) (62,469 ) (55,283 ) Equity in net (income) loss of unconsolidated affiliates (123 ) (1,344 ) (11,972 ) 295 Other non-operating gains (3,255 ) — (79,826 ) (11,046 ) Impairment of assets 10,810 — 144,481 140,053 Other reconciling items, net 204 (309 ) (13,647 ) (309 ) Adjusted EBITDA $ 68,856 $ 104,013 $ 253,120 $ 388,985 Add: Loss from Contigo Health (a) 2,252 2,032 7,315 7,206 Adjusted EBITDA excluding Contigo Health $ 71,108 $ 106,045 $ 260,435 $ 396,191 (a) Contigo Health was in a loss position which results in an increase to adjusted EBITDA and adjusted EPS when excluding Contigo Health. Income before income taxes $ 25,101 $ 86,584 $ 98,049 $ 146,521 Equity in net (income) loss of unconsolidated affiliates (123 ) (1,344 ) (11,972 ) 295 Interest expense, net 6,305 73 17,223 662 Other income, net (6,419 ) (2,332 ) (102,184 ) (20,832 ) Operating income 24,864 82,981 1,116 126,646 Depreciation and amortization 20,052 20,636 79,442 81,728 Amortization of purchased intangible assets 9,499 9,794 38,189 47,026 Stock-based compensation 7,669 205 23,700 23,876 Acquisition- and disposition-related expenses 2,520 4,117 6,943 12,612 Strategic initiative and restructuring-related expenses 6,914 (119 ) 13,007 2,850 Operating income from revenues sold to OMNIA (16,840 ) (15,624 ) (62,469 ) (55,283 ) Deferred compensation plan expense 3,165 1,400 4,603 8,769 Impairment of assets 10,810 — 144,481 140,053 Other reconciling items, net 203 623 4,108 708 Adjusted EBITDA $ 68,856 $ 104,013 $ 253,120 $ 388,985 SEGMENT ADJUSTED EBITDA Supply Chain Services $ 89,986 $ 109,617 $ 326,902 $ 409,669 Performance Services 17,170 32,820 60,692 113,845 Corporate (38,300 ) (38,424 ) (134,474 ) (134,529 ) Adjusted EBITDA $ 68,856 $ 104,013 $ 253,120 $ 388,985 Net income attributable to stockholders $ 18,435 $ 60,676 $ 20,269 $ 119,544 Net loss (income) from discontinued operations, net of tax 137 256 41,901 (2,500 ) Income tax expense 7,083 25,723 25,315 42,302 Amortization of purchased intangible assets 9,499 9,794 38,189 47,026 Stock-based compensation 7,669 205 23,700 23,876 Acquisition- and disposition-related expenses 2,520 4,117 6,943 12,612 Strategic initiative and restructuring-related expenses 6,914 (119 ) 13,007 2,850 Operating income from revenues sold to OMNIA (16,840 ) (15,624 ) (62,469 ) (55,283 ) Equity in net (income) loss of unconsolidated affiliates (123 ) (1,344 ) (11,972 ) 295 Other non-operating gains (3,255 ) — (79,826 ) (11,046 ) Impairment of assets 10,810 — 144,481 140,053 Other reconciling items, net 4,181 4,647 16,451 6,087 Adjusted income before income taxes 47,030 88,331 175,989 325,816 Income tax expense on adjusted income before income taxes 11,287 23,849 42,237 87,970 Adjusted net income $ 35,743 $ 64,482 $ 133,752 $ 237,846 Expand Supplemental Financial Information Reconciliation of GAAP EPS to Adjusted EPS (Unaudited) (In thousands, except per share data) Three Months Ended Year Ended June 30, June 30, 2025 2024 2025 2024 Net income attributable to stockholders $ 18,435 $ 60,676 $ 20,269 $ 119,544 Net loss (income) from discontinued operations, net of tax 137 256 41,901 (2,500 ) Income tax expense 7,083 25,723 25,315 42,302 Amortization of purchased intangible assets 9,499 9,794 38,189 47,026 Stock-based compensation 7,669 205 23,700 23,876 Acquisition- and disposition-related expenses 2,520 4,117 6,943 12,612 Strategic initiative and restructuring-related expenses 6,914 (119 ) 13,007 2,850 Operating income from revenues sold to OMNIA (16,840 ) (15,624 ) (62,469 ) (55,283 ) Equity in net (income) loss of unconsolidated affiliates (123 ) (1,344 ) (11,972 ) 295 Other non-operating gains (3,255 ) — (79,826 ) (11,046 ) Impairment of assets 10,810 — 144,481 140,053 Other reconciling items, net 4,181 4,647 16,451 6,087 Adjusted income before income taxes 47,030 88,331 175,989 325,816 Income tax expense on adjusted income before income taxes 11,287 23,849 42,237 87,970 Adjusted net income $ 35,743 $ 64,482 $ 133,752 $ 237,846 Weighted average: Basic weighted average shares outstanding 82,378 104,838 91,228 113,791 Dilutive shares 1,213 758 689 617 Weighted average shares outstanding - diluted 83,591 105,596 91,917 114,408 Basic earnings per share attributable to stockholders $ 0.22 $ 0.58 $ 0.22 $ 1.05 Net loss (income) from discontinued operations, net of tax — — 0.46 (0.02 ) Income tax expense 0.09 0.25 0.28 0.37 Amortization of purchased intangible assets 0.12 0.09 0.42 0.41 Stock-based compensation 0.09 — 0.26 0.21 Acquisition- and disposition-related expenses 0.03 0.04 0.08 0.11 Strategic initiative and restructuring-related expenses 0.08 — 0.14 0.03 Operating income from revenues sold to OMNIA (0.20 ) (0.15 ) (0.68 ) (0.49 ) Equity in net (income) loss of unconsolidated affiliates — (0.01 ) (0.13 ) — Other non-operating gains (0.04 ) — (0.88 ) (0.10 ) Impairment of assets 0.13 — 1.58 1.23 Other reconciling items, net 0.06 0.04 0.18 0.05 Impact of corporation taxes (0.14 ) (0.23 ) (0.46 ) (0.77 ) Impact of dilutive shares (0.01 ) — (0.01 ) — Adjusted earnings per share $ 0.43 $ 0.61 $ 1.46 $ 2.08 Add: Loss from Contigo Health (a) 0.03 0.03 0.08 0.09 Adjusted earnings per share excluding Contigo Health $ 0.46 $ 0.64 $ 1.54 $ 2.17 Expand _________________________________ (a) Contigo Health was in a loss position which results in an increase to adjusted EBITDA and adjusted EPS when excluding Contigo Health. Expand Supplemental Financial Information Reconciliation of Certain Financial Measures to Adjust for Contigo Health (Unaudited) (In thousands) Three Months Ended Year Ended June 30, June 30, 2025 2024 2025 2024 Net revenue $ 262,857 $ 300,246 $ 1,012,647 $ 1,136,009 Less: Contigo Health (4,885 ) (8,585 ) (26,694 ) (39,846 ) Net revenue excluding Contigo Health $ 257,972 $ 291,661 $ 985,953 $ 1,096,163 Adjusted EPS $ 0.43 $ 0.61 $ 1.46 $ 2.08 Add: Loss from Contigo Health (a) 0.03 0.03 0.08 0.09 Adjusted EPS excluding Contigo Health $ 0.46 $ 0.64 $ 1.54 $ 2.17 Expand _________________________________ (a) Contigo Health was in a loss position which results in an increase to adjusted EBITDA and adjusted EPS when excluding Contigo Health. Expand
Business Wire
a few seconds ago
- Business Wire
Wallbox Regains Compliance with NYSE Listing Standards
BARCELONA, Spain--(BUSINESS WIRE)--Wallbox N.V. (NYSE:WBX), a leading provider of electric vehicle charging and energy management solutions worldwide, today announced that it has regained compliance with the New York Stock Exchange ('NYSE') continued listing standard for minimum share price under Section 802.01C of the NYSE Listed Company Manual. Wallbox received written confirmation from the NYSE that, as of August 14, 2025, the Company's Class A ordinary shares had a closing share price of at least $1.00 and had maintained an average closing share price of at least $1.00 over the 30 trading-day period ending on that date. Accordingly, Wallbox is no longer considered to be below the minimum share price requirement of Section 802.01C and has regained compliance with the NYSE continued listing standards. Wallbox previously announced that it implemented a reverse stock split of its ordinary shares, effective July 3, 2025, to address the share price deficiency and support continued compliance with NYSE listing requirements. Wallbox's Class A ordinary shares will continue to be traded on the NYSE, subject to its continued compliance with all applicable listing standards. About Wallbox Wallbox is a global technology company, dedicated to changing the way the world uses energy. Wallbox creates advanced electric vehicle charging and energy management systems that redefine the relationship between users and the network. Wallbox goes beyond charging electric vehicles to give users the power to control their consumption, save money and live more sustainably. Wallbox offers a complete portfolio of charging and energy management solutions for residential, semi-public, and public use in more than 100 countries around the world. Founded in 2015 in Barcelona, where the Company's headquarters are located, Wallbox currently has offices across Europe, Asia, and America. For more information, visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the continued listing of Wallbox's Class A ordinary shares on the NYSE. The words 'anticipate,' 'believe,' 'can,' 'continue,' 'could,' 'estimate,' 'expect,' 'focus,' 'forecast,' 'intend,' 'likely,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' ''target,' will,' 'would' and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: Wallbox's history of operating losses; the adoption and demand for electric vehicles including the success of alternative fuels, changes to rebates, tax credits and the impact of government incentives or reduction thereof; political and economic uncertainty and macroeconomic factors, such as impacts from tariffs and trade barriers, geopolitical conflicts, consumer spending, inflation and foreign exchange rates; the accuracy of Wallbox's forecasts and projections including those regarding its market opportunity; competition; risks related to losses or disruptions in Wallbox's supply or manufacturing partners; Wallbox's reliance on the third-parties outside of its control; risks related to Wallbox's technology, intellectual property and infrastructure; executive orders and regulatory changes under the U.S. political administration and uncertainty therefrom; as well as the other important factors discussed under the caption 'Risk Factors' in Wallbox's Annual Report on Form 20-F for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in its other filings with the Securities and Exchange Commission (the 'SEC'), accessible on the SEC's website at and the Investors Relations section of Wallbox's website at Any such forward-looking statements represent management's estimates as of the date of this press release. Any forward-looking statement that Wallbox makes in this press release speaks only as of the date of such statement. Except as required by law, Wallbox disclaims any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise.
Business Wire
a few seconds ago
- Business Wire
HEINZ Launches Irresistible New Mayonnaise-Style Sauces, Bringing Flavour to Every Bite
TORONTO--(BUSINESS WIRE)--HEINZ turns up the flavour for Canadians, with the launch of new HEINZ Mayonnaise-Style Sauces, expanding its range of delicious condiment options in Canada. The new lineup is crafted for sauce lovers and made to satisfy consumers' growing craving for more adventurous options in the kitchen. With more than half of Canadians saying they need at least 2-3 sauces with their meals,1 this new lineup delivers a flavour-forward and delicious way to elevate any at-home meal and meet Canadians' sauce needs. Starting today, fans nationwide can now enjoy eight crave-worthy HEINZ Mayo Sauces*, including four new flavours: Smoky Bacon, Garlic Parmesan, Mango Habanero and Pickle. These new additions reflect the country's deep-rooted love for mayo as nearly two-thirds of Canadians rank it among their top five condiments along with three quarters of residents in Quebec1. With this expanded lineup, HEINZ is giving Canadians even more craveable ways to enjoy their favourite dippable foods. 'At HEINZ, we know that Canadians crave bold and delicious flavours, and we're thrilled to introduce our new lineup of HEINZ Mayonnaise-Style Sauces to shake up the mayo category and give Canadians more exciting dipping options,' said Jenna Zylber, Head of Innovation at Kraft Heinz Canada. 'As a brand, HEINZ has been a staple for Canadian households for generations and we're proud to expand our portfolio with delicious new options that are so irresistible, you won't be able to stop at just one dip!' While mayo may be in the top five when it comes to condiments, flavoured options on the market are limited, causing the nearly three quarters of Canadians who dip mayo to have to mix it with other sauces like ketchup or hot sauce2. With flavour as king and nothing stopping irrational mayo lovers from finding the perfect mix, these new innovative offerings remove the extra step and create the perfect flavour pairing. Dip into your favourite foods with exciting new taste combinations including: HEINZ Smoky Bacon Flavour Mayonnaise-Style Sauce: A bold blend of smoky bacon flavour and creamy mayonnaise, perfect for adding savoury depth to chicken tenders, fries, onion rings and mozzarella sticks. A bold blend of smoky bacon flavour and creamy mayonnaise, perfect for adding savoury depth to chicken tenders, fries, onion rings and mozzarella sticks. HEINZ Garlic Parmesan Flavour Mayonnaise-Style Sauce: Layering fragrant garlic and creamy parmesan flavour, ideal for dipping kabobs, fries, potato wedges, samosas and chicken tenders. Layering fragrant garlic and creamy parmesan flavour, ideal for dipping kabobs, fries, potato wedges, samosas and chicken tenders. HEINZ Mango Habanero Mayonnaise-Style Sauce: A fusion of sweet mango and spicy habanero, bring a balanced kick to onion rings, chicken tenders, coconut shrimp and fries. A fusion of sweet mango and spicy habanero, bring a balanced kick to onion rings, chicken tenders, coconut shrimp and fries. HEINZ Pickle Mayonnaise-Style Sauce: A tangy twist of pickles and creamy mayonnaise best paired with chicken wings, fries, nuggets, onion rings and more. With craveable flavours in every bite, the new HEINZ Mayo Sauces* are so irresistible, Canadians might just find themselves double dipping to enjoy more of the exciting flavours. They wouldn't be alone either, as nearly two-thirds of Canadians admit to double dipping when no one's around1, but with HEINZ Mayo Sauces* it's time to dip freely! The all-new HEINZ Mayo Sauces* round out the full, craveable lineup with other fan favourite flavours including Mayochup, Sriracha, Garlic and Real Mayonnaise and are now available nationwide at major retailers across Canada. To learn more about the new HEINZ Mayonnaise-Style Sauces and HEINZ's ever-evolving portfolio, visit our website and follow @Heinz_CA on Instagram and TikTok. ABOUT THE KRAFT HEINZ COMPANY Kraft Heinz Canada's heritage can be traced back over a century to when James Lewis Kraft of Stevensville, Ontario began selling cheese from a horse-drawn wagon in 1903. Heinz Canada was established in 1909 in Leamington, Ontario where its first products were pickles sourced from local growers. Following the 2015 merger between KraftFoods Group and H.J. Heinz Company, Kraft Heinz Canada became a subsidiary of the newly formed Kraft Heinz Company (NASDAQ: KHC). Now the country's second largest food and beverage company, iconic Kraft Heinz Canada products like Kraft Peanut Butter, Heinz Ketchup, KD, Philadelphia Cream Cheese, Renée's Dressing, Jell-O, Classico, Kool-Aid and Maxwell House are found in over 97 percent of Canadian households. Kraft Heinz Canada is driving transformation inspired by Kraft Heinz's global purpose, Let's Make Life Delicious, by creating memorable community moments through local initiatives such as Kraft Heinz Project Play and Kraft Hockeyville, while also supporting food banks across Canada through Kraft Heinz Project Pantry. Learn more about our journey by visiting or following us on LinkedIn. ______________________________ 1 Conducted by The Harris Poll Canada on behalf of Kraft Heinz Canada. It ran overnight on August 4, 2025, with 1,526 randomly selected Canadian adults who are Maru Voice Canada online panelists. 2 Canvas8 2024, Heinz Taps Into Gen Z's Customization Desires * HEINZ Mayonnaise-Style Sauces Expand
